LEXX - Lexaria Bioscience Corp. Trailing Twelve Months Revenue Growth

Graphic logo of lexariabioscience.com (LEXX)

Lexaria Bioscience generates revenue through the licensing of its DehydraTECH platform designed to enhance drug absorption. The current sales growth rate over a rolling 12-month period year-over-year confirms the revenue trend, where -68.30 captures the current value of the indicator. Innovations reduce chemical waste by lowering substance dosages, while the outsourcing of manufacturing plants minimizes the internal environmental footprint while maintaining strict biosafety compliance.

Lexaria Bioscience Corp (LEXX) - Sales Growth YoY (TTM) from 02/11/2024 to 11/15/2026

lexariabioscience.com (LEXX) - metric breakdowns and financial figures

- stock price and consensus target price:
Price Chart Lexaria|LEXX - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Lexaria|LEXX - Real Price to Acquire Entire Company
- book capitalization data:
Equity per Share Lexaria Bioscience|LEXX - Book Capitalization|Market Capitalization to Book Value Ratio lexariabioscience.com|LEXX - Aggregate Company Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Lexaria Bioscience|LEXX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Lexaria|LEXX - Company Aggregate Debts|Debts to Book Capitalization Lexaria|LEXX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Lexaria Bioscience|Quick Liquidity lexariabioscience.com
- earnings and valuation multiples indicators:
LEXX - Net Profit|Company Profit Forecast Lexaria Bioscience|LEXX - Price to Earnings Ratio|Projected Price to Earnings Ratio Lexaria Bioscience|LEXX - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Lexaria Bioscience Corp.|LEXX - Operating profit EBITDA|Net earnings per share for the last 12 months Lexaria Bioscience|LEXX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months lexariabioscience.com|LEXX - Earnings growth in current year|Expected net earnings per share growth next year Lexaria Bioscience
- sales revenue and business income indicators:
LEXX - Company Revenue|Company Revenue Forecast Lexaria|LEXX - P/S Multiple|Forward Price-to-Revenue Multiple Lexaria Bioscience Corp.|LEXX - Sales Growth YoY (TTM)
Summary company analytics:LEXX (Lexaria Bioscience Corp)
Brand item of Lexaria Bioscience

This indicator reflects the dynamics of annual revenue over a twelve-month period on a daily basis. By analyzing the 12-month year-over-year revenue growth rate on GURU.Markets, an investor assesses the business's resilience to inflationary costs. Sales growth does not guarantee a rise in quotes if net profit declines. For Lexaria Bioscience (LEXX), this metric confirms the effectiveness of patent licensing. Delegating production to CDMO partners minimizes operational risks during scaling.

Competitor analysis for Lexaria Bioscience

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|RLYB - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)